FDA Inspection 1041864 — Mobius Therapeutics, LLC
The FDA completed an inspection of Mobius Therapeutics, LLC on Feb 6, 2018 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 6, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Saint Louis, MO (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)